Simultaneous Pancreas-kidney Transplantation With Campath Protocol

NCT00316810 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreas-Kidney Transplantation

Interventions

DRUG: Alemtuzumab
DRUG: Rabbit Anti-Human Thymocyte Globulin

Sponsor

Dr. Claudia Bösmüller

Collaborators

[object Object]